Skip to main content
. 2014 Oct 21;17(8):692–697. doi: 10.1177/1098612X14555441

Figure 1.

Figure 1

Flow chart describing assessment for eligibility, enrollment, allocation, outcome and analysis of cats with chronic kidney disease for the maropitant study, which was a placebo-controlled, blinded clinical trial. *Medication was discontinued as the owner could no longer successfully administer it. Subsequently discovered to be the other cat in the household that was vomiting